Pharmafile Logo

SC Marketing

SC Marketing was founded in 2006 by Steve Clark and offers specialist marketing skills for the pharmaceutical industry and allied agencies. SC Marketing can offer you support on a project consultancy basis or interim / vacancy management cover. SC Marketing has extensive global and UK domestic experience in strategic planning and operational delivery – a flexible resource to suit your needs. So whether you need someone to develop a new campaign, build a strategic plan or simply be a fresh brain to challenge existing thinking, contact SC Marketing.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

51 Loosen Drive, Maidenhead, Berkshire, SL6 3UT, United Kingdom
+44 (0)7788 143444

 Latest Content from PMHub 

Precision medicine at Blue Latitude Health

At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

The first of many celebrations for Lucid Group at Middlesex House

Lucid Group celebrated the opening of its new offices in Fitzrovia, London on Thursday evening. The workspace in Middlesex House is incredible, allowing employees to take advantage of well-designed creative,...

Lucid Group welcomes three new graduates ahead of the 2020 Futures Academy

Three new graduates have joined the Lucid Group family ahead of the launch of the 2020 Futures Academy in January.Having completed a Natural Sciences degree from Lancaster University, Tom Harrison...

Understanding the evolving CAR-T market

In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in...

Rewarding Long Service at Bedrock

Katie Penfold celebrates 5 years with the Bedrock Group

Restoring Equilibrium at Lucid Group

It’s National Stress Awareness Day, which is a great opportunity to take a moment to think about our wellbeing. This time of year is often busier than normal. At Lucid,...

Lucid Group celebrates a fang-tastic Halloween

Last week the Lucid charity working group, Lucid SPIRIT, organised a fang-tastic Halloween Bingo evening to raise money for its charity partner, Wycombe Homeless Connection (WHC).Lucidians went to town with...

OPEN Health announces the integration of Pharmerit International into the group

Press Releases | November 4, 2019 | OPEN Health

OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.

Article: Market access in Brazil

White Papers and Resources | November 1, 2019 | Inizio

All eyes on Spinraza

China: How to strategise and win in the world’s fastest changing healthcare market

White Papers and Resources | November 1, 2019 | Inizio

In this paper, experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch...